Natera Says Fed. Circ. Panel Rightly Axed DNA Test Patents
Genetic testing company Natera has urged the full Federal Circuit not to review a panel's decision agreeing that three Stanford University diagnostic patents are ineligible for protection, arguing the panel didn't...To view the full article, register now.
Already a subscriber? Click here to view full article